IRON
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
Monday, July 14, 2025 BiopharmaWatch Research 1 min read Key Takeaway: Disc Medicine Appoints Nadim Ahmed to its Board of Directors
Price reaction · baseline $56.91 (2025-07-11 close) · clean, no other IRON news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+45%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Cash runway
~48 mo
Minimal dilution risk
Lead asset
DISC-0974
Phase 2 · Inflammatory Bowel Disease (IBD)
Full Press Release Details
Disc Medicine Appoints Nadim Ahmed to its Board of Directors.